Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

New Drug Application (NDA): 012928
Company: LILLY
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS EQ 50MG BASE/5ML SUSPENSION;ORAL Discontinued None No No
NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS EQ 100MG BASE CAPSULE;ORAL Discontinued None No No
NOVRAD LEVOPROPOXYPHENE NAPSYLATE ANHYDROUS EQ 50MG BASE CAPSULE;ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/21/1962 ORIG-1 Approval Type 3 - New Dosage Form STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
06/09/1981 SUPPL-12 Labeling

Label is not available on this site.

03/11/1980 SUPPL-11 Manufacturing (CMC)-Control

Label is not available on this site.

02/17/1978 SUPPL-10 Labeling

Label is not available on this site.

08/24/1976 SUPPL-9 Manufacturing (CMC)-Formulation

Label is not available on this site.

08/24/1976 SUPPL-8 Manufacturing (CMC)-Formulation

Label is not available on this site.

08/23/1976 SUPPL-7 Manufacturing (CMC)-Control

Label is not available on this site.

05/08/1972 SUPPL-2 Labeling

Label is not available on this site.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English